Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,937.20
(
-0.32%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.74
(
2.48%
)
Bitcoin
73,698.62
(
-1.53%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 512
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 123920

Tuesday, 07/26/2011 9:26:39 AM

Tuesday, July 26, 2011 9:26:39 AM

Post# of 257250

Copaxone vs Tysabri



Do you expect Copaxone to post as impressive of a growth rate?
I suspect it's losing more patients to Gylenia.

Btw, what was the original reasoning for comparing/contrasting Tysabri vs. Copaxone? Why not think of Copaxone within the usual ABCR competitive basket?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now